CBT
Price
$73.46
Change
-$0.83 (-1.12%)
Updated
Oct 19, 04:59 PM (EDT)
Capitalization
3.84B
13 days until earnings call
Intraday BUY SELL Signals
OEC
Price
$5.36
Change
+$0.02 (+0.37%)
Updated
Oct 19, 04:59 PM (EDT)
Capitalization
301.83M
10 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

CBT vs OEC

CBT vs OEC Comparison Chart in %
View a ticker or compare two or three
VS
CBT vs. OEC commentary
Oct 20, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CBT is a Hold and OEC is a Hold.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for CBT with price predictions
Oct 19, 2026

CBT's Stochastic Oscillator is remaining in oversold zone for 7 days

The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an uptrend is expected.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Indicator entered the oversold zone -- be on the watch for CBT's price rising or consolidating in the future. That's also the time to consider buying the stock or exploring call options.

Following a +1.35% 3-day Advance, the price is estimated to grow further. Considering data from situations where CBT advanced for three days, in 209 of 311 cases, the price rose further within the following month. The odds of a continued upward trend are 67%.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on October 06, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on CBT as a result. In 65 of 96 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 68%.

The Moving Average Convergence Divergence Histogram (MACD) for CBT turned negative on October 19, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 50 similar instances when the indicator turned negative. In 28 of the 50 cases the stock turned lower in the days that followed. This puts the odds of success at 56%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where CBT declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 67%.

The Aroon Indicator for CBT entered a downward trend on October 19, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 4 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Valuation Rating of 61 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.390) is normal, around the industry mean (2.342). P/E Ratio (20.694) is within average values for comparable stocks, (-17.016). Projected Growth (PEG Ratio) (0.320) is also within normal values, averaging (1.548). Dividend Yield (0.025) settles around the average of (0.039) among similar stocks. P/S Ratio (1.138) is also within normal values, averaging (48.960).

The Tickeron Price Growth Rating for this company is 61 (best 1 - 100 worst), indicating fairly steady price growth. CBT’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 65 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 65 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 82, placing this stock slightly better than average.

A.I.Advisor
a Summary for OEC with price predictions
Oct 16, 2026

OEC sees its 50-day moving average cross bearishly below its 200-day moving average

The 50-day moving average for OEC moved below the 200-day moving average on September 29, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on October 15, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on OEC as a result. In 69 of 84 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 82%.

The Moving Average Convergence Divergence Histogram (MACD) for OEC turned negative on October 16, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 45 similar instances when the indicator turned negative. In 37 of the 45 cases the stock turned lower in the days that followed. This puts the odds of success at 82%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where OEC declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 77%.

The Aroon Indicator for OEC entered a downward trend on October 12, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Indicator entered the oversold zone -- be on the watch for OEC's price rising or consolidating in the future. That's also the time to consider buying the stock or exploring call options.

The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.

Following a +3.72% 3-day Advance, the price is estimated to grow further. Considering data from situations where OEC advanced for three days, in 220 of 310 cases, the price rose further within the following month. The odds of a continued upward trend are 71%.

OEC may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 27 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.794) is normal, around the industry mean (2.344). P/E Ratio (-3.141) is within average values for comparable stocks, (-17.061). Projected Growth (PEG Ratio) (0.040) is also within normal values, averaging (1.548). Dividend Yield (0.016) settles around the average of (0.039) among similar stocks. P/S Ratio (0.177) is also within normal values, averaging (48.960).

The Tickeron Price Growth Rating for this company is 74 (best 1 - 100 worst), indicating slightly worse than average price growth. OEC’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 96 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is 97 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. OEC’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 81, placing this stock worse than average.

FUNDAMENTALS RATINGS
CBT vs OEC: Fundamental Ratings
CBT
OEC
OUTLOOK RATING
1..100
5469
VALUATION
overvalued / fair valued / undervalued
1..100
61
Fair valued
27
Undervalued
PROFIT vs RISK RATING
1..100
65100
SMR RATING
1..100
6596
PRICE GROWTH RATING
1..100
6174
P/E GROWTH RATING
1..100
497
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

OEC's Valuation (27) in the Chemicals Specialty industry is somewhat better than the same rating for CBT (61) in the Industrial Specialties industry. This means that OEC’s stock grew somewhat faster than CBT’s over the last 12 months.

CBT's Profit vs Risk Rating (65) in the Industrial Specialties industry is somewhat better than the same rating for OEC (100) in the Chemicals Specialty industry. This means that CBT’s stock grew somewhat faster than OEC’s over the last 12 months.

CBT's SMR Rating (65) in the Industrial Specialties industry is in the same range as OEC (96) in the Chemicals Specialty industry. This means that CBT’s stock grew similarly to OEC’s over the last 12 months.

CBT's Price Growth Rating (61) in the Industrial Specialties industry is in the same range as OEC (74) in the Chemicals Specialty industry. This means that CBT’s stock grew similarly to OEC’s over the last 12 months.

CBT's P/E Growth Rating (4) in the Industrial Specialties industry is significantly better than the same rating for OEC (97) in the Chemicals Specialty industry. This means that CBT’s stock grew significantly faster than OEC’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CBTOEC
RSI
ODDS (%)
Bullish Trend 1 day ago
77%
Bullish Trend 4 days ago
82%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
81%
Bullish Trend 4 days ago
67%
Momentum
ODDS (%)
Bearish Trend 1 day ago
68%
Bearish Trend 4 days ago
82%
MACD
ODDS (%)
Bearish Trend 1 day ago
56%
Bearish Trend 4 days ago
82%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
67%
Bearish Trend 4 days ago
76%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
68%
Bearish Trend 4 days ago
77%
Advances
ODDS (%)
Bullish Trend 15 days ago
67%
Bullish Trend 15 days ago
71%
Declines
ODDS (%)
Bearish Trend 1 day ago
67%
Bearish Trend 4 days ago
77%
BollingerBands
ODDS (%)
N/A
Bullish Trend 4 days ago
69%
Aroon
ODDS (%)
Bearish Trend 1 day ago
69%
Bearish Trend 4 days ago
80%
COMPARISON
Comparison
Oct 20, 2026
Stock price -- (CBT: $73.46 vs. OEC: $5.36)
Brand notoriety: CBT and OEC are both not notable
Both companies represent the Chemicals: Specialty industry
Current volume relative to the 65-day Moving Average: CBT: 93% vs. OEC: 118%
Market capitalization -- CBT: $3.84B vs. OEC: $301.83M
CBT [@Chemicals: Specialty] is valued at $3.84B. OEC’s [@Chemicals: Specialty] market capitalization is $301.83M. The market cap for tickers in the [@Chemicals: Specialty] industry ranges from $50 to $232.08B. The average market capitalization across the [@Chemicals: Specialty] industry is $11.43B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CBT’s FA Score shows that 1 FA rating(s) are green while OEC’s FA Score has 1 green FA rating(s).

  • CBT’s FA Score: 1 green, 4 red.
  • OEC’s FA Score: 1 green, 4 red.
According to our system of comparison, both CBT and OEC are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CBT’s TA Score shows that 3 TA indicator(s) are bullish while OEC’s TA Score has 4 bullish TA indicator(s).

  • CBT’s TA Score: 3 bullish, 4 bearish.
  • OEC’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, both CBT and OEC are a bad buy in the short-term.

Price Growth

CBT (@Chemicals: Specialty) experienced а -1.08% price change this week, while OEC (@Chemicals: Specialty) price change was -5.13% for the same time period.

The average weekly price growth across all stocks in the @Chemicals: Specialty industry was -2.72%. For the same industry, the average monthly price growth was -4.64%, and the average quarterly price growth was -6.17%.

Reported Earning Dates

CBT is expected to report earnings on Nov 02, 2026.

OEC is expected to report earnings on Nov 04, 2026.

Industries' Descriptions

@Chemicals: Specialty (-2.72% weekly)

The specialty chemicals sector includes companies that produce chemicals and industrial gases, which are of relatively high-value, often made to customer specifications. Examples of specialty chemicals are electronic chemicals, industrial gases, coatings, adhesives and sealants, industrial and institutional cleaning chemicals. The products are often valued on the basis of their purposes/performances rather than for their composition. Linde Plc, Ecolab Inc., Air Products and Chemicals, Inc., and Dow, Inc. are some of the largest companies making specialty chemicals.

View a ticker or compare two or three
CBT
Daily Signal:
Gain/Loss:
OEC
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
SHOC100.311.83
+1.86%
Strive U.S. Semiconductor ETF (SHOC)
JUNM35.520.05
+0.14%
FT Vest U.S. Equity Max Buffer ETF - June (JUNM)
TFLR50.350.01
+0.01%
T. Rowe Price Floating Rate ETF (TFLR)
VONV112.05-0.10
-0.09%
Vanguard Russell 1000 Value ETF (VONV)
VDI35.41-0.14
-0.39%
Virtus International Dividend ETF (VDI)